|
H100 Hemoglobin Analyzer (HbA1c HPLC System) – High-Precision Diabetes & Thalassemia Testing
As metabolic and genetic blood disorders become more prevalent in Asia, laboratories are demanding analyzers that can perform both diabetes monitoring and thalassemia screening without sacrificing throughput. The H100 addresses this dual workload.
The H100 Hemoglobin Analyzer is a fully automated HPLC system designed for high-precision HbA1c detection and hemoglobin variant analysis. It operates in two distinct modes: a 96-second HbA1c test for diabetes monitoring, and a 350-second thalassemia screening mode that automatically flags abnormal variants using V-win reporting software.
One-click switching between modes means a single instrument can replace two dedicated analyzers — a practical choice for labs that process mixed patient populations. The sample loader supports up to 110 positions with automated inversion mixing, reducing manual handling and improving result consistency across batches.
Certified to both NGSP and IFCC reference standards, the H100 meets international requirements for diabetes diagnostics while also supporting regional screening programs for β-thalassemia — a genetic condition that affects millions across southern China, Southeast Asia, and the Mediterranean.
From a procurement perspective, the H100 represents a clear operational logic: reduce capital expenditure by consolidating two workflows into one device. Its Linux-based interface and 20,000-result data storage also simplify training and compliance in high-volume settings.
China’s diagnostic manufacturing ecosystem now produces instruments that compete directly with legacy Japanese and European HPLC platforms, but with more flexible feature bundling — such as integrated thalassemia analysis — aimed specifically at regional disease burdens.
The H100 is a practical distillation of where clinical diagnostics are heading: not just faster, but smarter about which tests are combined into a single automated workflow.
Why it matters:
For labs running both diabetes and thalassemia panels, the H100 reduces equipment footprint, lowers per-test cost, and eliminates sample splitting. It also signals how Chinese OEMs are building disease-specific intelligence into general-purpose HPLC platforms.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|
No products in the cart.